Structure–Activity Relationship of Penem Antibiotic Side Chains Used against Mycobacteria Reveals Highly Active Compounds-Reference-Cited by-同舟云学术

Structure–Activity Relationship of Penem Antibiotic Side Chains Used against Mycobacteria Reveals Highly Active Compounds

Published:2022-08-02 Issue:8 Volume:8 Page:1627-1636
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Batchelder Hunter R.¹,Zandi Trevor A.²,Kaushik Amit³,Naik Akul¹,Story-Roller Elizabeth³,Maggioncalda Emily C.³,Lamichhane Gyanu³,Nuermberger Eric L.³,Townsend Craig A.¹^ORCID

Affiliation:

1. Department of Chemistry, Johns Hopkins University, Baltimore, Maryland 21218, United States

2. T. C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, Maryland 21218, United States

3. Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, United States

Funder

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.2c00229

Reference47 articles.

1. Tuberculosis. https://www.who.int/health-topics/tuberculosis#tab=tab_1 (accessed Jul 26, 2021).

2. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network